cDNA microarray to study gene expression of dopaminergic neurodegeneration and neuroprotection in MPTP and 6-hydroxydopamine models: Implications for idiopathic Parkinson's disease

Journal of Neural Transmission, Supplement

Volumn , Issue 60, 2000, Pages 117-124

  Mandel, S ^a   Grunblatt E ^a   Youdim, M B H ^a  

^a TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; APOMORPHINE; COMPLEMENTARY DNA; EPIDERMAL GROWTH FACTOR; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; GLUTAMATE RECEPTOR; HEAT SHOCK PROTEIN; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 6; NITRIC OXIDE SYNTHASE; OXIDOPAMINE; TRANSFERRIN RECEPTOR; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; CONFERENCE PAPER; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; GENE EXPRESSION REGULATION; MALE; MOUSE; NERVE DEGENERATION; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; OXIDATIVE STRESS; PARKINSON DISEASE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

EID: 0034517802     PISSN: 03036995     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-3-7091-6301-6_7     Document Type: Conference Paper

References (19)

1. IL-1β, IL-2, IL-6 and TNF-α production by peripheral blood mononuclear cells from patients with Parkinson's disease
2. Vitamin E attenuates the toxic effects of intrastriatal injection of 6-hydroxydopamine (6-OHDA) in rats: Behavioral and biochemical evidence
3. DNA microarrays in drug discovery and development
4. Apomorphine enantiomers protect cultured pheochromocytoma (PC12) cells from oxidative stress induced by H2O2 and 6-hydroxydopamine
5. Altered brain metabolism of iron as a cause of neurodegenerative diseases?
6. Apomorphine protects against MPTP-induced neurotoxicity in mice
7. Gene expression analysis in MPTP model of Parkinson's disease using cDNA microarray
8. Alterations of oxidative-stress and inflammatory gene expression in MPTP-induced neurotoxicity and their prevention by R-apomorphine
9. Epidermal growth factor enhances striatal dopaminergic parameters in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated mouse
10. Nuclear translocation of NF-κB is increased in dopaminergic neurons of patients with Parkinson's disease
11. Brain iron and ferritin in Parkinson's and Alzheimer's disease
12. Oxidative stress and the pathogenesis of Parkinson's disease
13. GDNF: A glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons
14. Role of iron in NFκB activation and cytokines gene expression by rat hepatic macrophages
15. Interleukin (IL)-1β, IL-2, IL-4, IL-6 and transforming growth factor-α levels are elevated in ventricular cerebrospinal fluid in juvenile parkinsonian and Parkinson's disease
16. Characterization of the Hsp110/SSE gene family response to hyperosmolarity and other stresses
17. Reactive oxygen intermediates as apparently widely used messengers in the reactivation of the NF-kappa B transcription factor and HIV-1
18. The possible role of iron in the etiopathology of Parkinson's disease
19. The pivotal role of iron in NF-B activation and nigro-striatal dopaminergic neurodegeneration; prospects for neuroprotection in Parkinson's Disease with iron chelators